Management of Corneal Clouding in Patients with Mucopolysaccharidosis

Mucopolysaccharidoses (MPS) are a rare group of lysosomal storage disorders characterized by the accumulation of incompletely degraded glycosaminoglycans (GAGs) in multiple organ systems including the eye. Visual loss occurs in MPS predominantly due to corneal clouding and retinopathy, but the scler...

Full description

Bibliographic Details
Main Authors: Orlaith McGrath, Leon Au, Jane Ashworth
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/10/15/3263
_version_ 1797525438206050304
author Orlaith McGrath
Leon Au
Jane Ashworth
author_facet Orlaith McGrath
Leon Au
Jane Ashworth
author_sort Orlaith McGrath
collection DOAJ
description Mucopolysaccharidoses (MPS) are a rare group of lysosomal storage disorders characterized by the accumulation of incompletely degraded glycosaminoglycans (GAGs) in multiple organ systems including the eye. Visual loss occurs in MPS predominantly due to corneal clouding and retinopathy, but the sclera, trabecular meshwork and optic nerve may all be affected. Despite the success of therapies such as enzyme replacement therapy (ERT) and hematopoietic stem-cell transplantation (HSCT) in improving many of the systemic manifestations of MPS, their effect on corneal clouding is minimal. The only current definitive treatment for corneal clouding is corneal transplantation, usually in the form of a penetrating keratoplasty or a deep anterior lamellar keratoplasty. This article aims to provide an overview of corneal clouding, its current clinical and surgical management, and significant research progress.
first_indexed 2024-03-10T09:13:53Z
format Article
id doaj.art-489d98f7db1d4857b6f32d163b1e2b08
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-10T09:13:53Z
publishDate 2021-07-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-489d98f7db1d4857b6f32d163b1e2b082023-11-22T05:48:13ZengMDPI AGJournal of Clinical Medicine2077-03832021-07-011015326310.3390/jcm10153263Management of Corneal Clouding in Patients with MucopolysaccharidosisOrlaith McGrath0Leon Au1Jane Ashworth2Manchester Royal Eye Hospital, Central Manchester University Hospitals NHS Foundation Trust, Oxford Road, Manchester M13 9WL, UKManchester Royal Eye Hospital, Central Manchester University Hospitals NHS Foundation Trust, Oxford Road, Manchester M13 9WL, UKManchester Royal Eye Hospital, Central Manchester University Hospitals NHS Foundation Trust, Oxford Road, Manchester M13 9WL, UKMucopolysaccharidoses (MPS) are a rare group of lysosomal storage disorders characterized by the accumulation of incompletely degraded glycosaminoglycans (GAGs) in multiple organ systems including the eye. Visual loss occurs in MPS predominantly due to corneal clouding and retinopathy, but the sclera, trabecular meshwork and optic nerve may all be affected. Despite the success of therapies such as enzyme replacement therapy (ERT) and hematopoietic stem-cell transplantation (HSCT) in improving many of the systemic manifestations of MPS, their effect on corneal clouding is minimal. The only current definitive treatment for corneal clouding is corneal transplantation, usually in the form of a penetrating keratoplasty or a deep anterior lamellar keratoplasty. This article aims to provide an overview of corneal clouding, its current clinical and surgical management, and significant research progress.https://www.mdpi.com/2077-0383/10/15/3263Mucopolysaccharidosiscorneal cloudingpenetrating keratoplastydeep anterior lamellar keratoplasty
spellingShingle Orlaith McGrath
Leon Au
Jane Ashworth
Management of Corneal Clouding in Patients with Mucopolysaccharidosis
Journal of Clinical Medicine
Mucopolysaccharidosis
corneal clouding
penetrating keratoplasty
deep anterior lamellar keratoplasty
title Management of Corneal Clouding in Patients with Mucopolysaccharidosis
title_full Management of Corneal Clouding in Patients with Mucopolysaccharidosis
title_fullStr Management of Corneal Clouding in Patients with Mucopolysaccharidosis
title_full_unstemmed Management of Corneal Clouding in Patients with Mucopolysaccharidosis
title_short Management of Corneal Clouding in Patients with Mucopolysaccharidosis
title_sort management of corneal clouding in patients with mucopolysaccharidosis
topic Mucopolysaccharidosis
corneal clouding
penetrating keratoplasty
deep anterior lamellar keratoplasty
url https://www.mdpi.com/2077-0383/10/15/3263
work_keys_str_mv AT orlaithmcgrath managementofcornealcloudinginpatientswithmucopolysaccharidosis
AT leonau managementofcornealcloudinginpatientswithmucopolysaccharidosis
AT janeashworth managementofcornealcloudinginpatientswithmucopolysaccharidosis